Approximately one-fourth of the general population worldwide has nonalcoholic fatty liver disease, known as NAFLD, an umbrella term for a range of liver conditions affecting people who drink little to no alcohol. NAFLD can ...
Nov 1, 2022
0
44
The European Medicines Agencies (EMA) recommended European countries include new warnings on labels and in package inserts of analgesics, or pain killers, that combine codeine and ibuprofen. This recommendation was agreed ...
Oct 27, 2022
0
5
Hepatitis A is an acute liver disease caused by the hepatitis A virus (HAV) and transmitted via the fecal-oral route through person-to-person transmission and contaminated food or water. While hepatitis A infection is mostly ...
Oct 24, 2022
0
4
Wearing a large hat protecting her face from the sun's rays in Cameroon, 63-year-old Jeanne now bitterly regrets using skin whitening products after being diagnosed with skin cancer.
Sep 29, 2022
0
2
The highly contagious Ebola virus has claimed more than 15,000 lives since it was first identified in central Africa in 1976.
Sep 20, 2022
0
7
The most common reasons why people with type 2 diabetes (T2DM) are admitted to hospital with greater frequency than the general population are changing, with hospitalization for traditional diabetes complications now being ...
Sep 1, 2022
0
20
Two children who received Zolgensma, a gene therapy produced by Swiss drugmaker Novartis to treat spinal muscular atrophy, have died from liver failure, the company said Friday.
Aug 12, 2022
0
13
Unexplained cases of acute liver inflammation in children, especially in the United Kingdom (U.K.), were reported earlier this year. In response, the European Reference Network on Hepatological Diseases (ERN RARE-LIVER) conducted ...
Aug 8, 2022
0
31
The buildup of fat in the liver, known as non-alcoholic fatty liver disease, or NAFLD for short, is linked to a heightened risk of heart failure over the next decade, finds a pooled data analysis of the available research, ...
Jul 25, 2022
0
35
A new mouse model identified by virologists from the University of Pittsburgh might revolutionize development of therapies targeting brain inflammation caused by Rift Valley Fever virus (RVFV).
Jul 14, 2022
0
36
